ImmunoCellular Therapeutics, Ltd. (the "Company") is filing information for the purpose of updating the description of its business included under the heading, "Item 1. Business" in the Company's Annual Report on Form 10-K for the year ended December 31, 2011, filed with the Securities and Exchange Commission (the "SEC") on March 21, 2012. The Company is also supplementing and updating certain risks and uncertainties from the description included under the heading, "Item 1A. Risk Factors" in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, filed with the SEC on August 14, 2012. The updated descriptions are filed herewith as Exhibit 99.1 and are incorporated herein by reference.

(d) Exhibits

             Exhibit
             Number    Description

             99.1      Updated Business Description and Risk Factors.